2m 2m 2m 2m 2m 2m 2m
Cellyan Biotec-A (HKPD)
NASDAQ
$0.51-$0.01 (-1.98%)
Price as of Jun 03, 2026 6:29 PM EDT- $787,500.00Market Cap
- -67.01%1-Year Change
- Medical DistributionIndustry
Cellyan Biotec-A (HKPD)
$0.51-$0.01 (-1.98%)
Annual
Quarterly
03/31/2025 | ||
|---|---|---|
Income Statement | ||
Total Operating Revenue | 20.3M N/A | |
Cost of Revenue | 17.9M N/A | |
Gross Profit | 2.4M N/A | |
Sales and Marketing Expense | 2.2M N/A | |
Research and Development Expense | N/A N/A | |
Depreciation and Amortization Expense | 75,766 N/A | |
Total Operating Expenses | 2.2M N/A | |
Operating Profit | -2.3M N/A | |
Interest Income | N/A N/A | |
Interest Expense | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | |
Total Nonoperating Income and Expense | 1,466 N/A | |
Income before Taxes | -27,056 N/A | |
Income Taxes | 63,168 N/A | |
Extraordinary Items | N/A N/A | |
Net Income | -27,056 N/A | |
Net Income from Continuing Operations Applicable to Common | -27,056 N/A | |
Basic EPS and Net Income | -0.003 N/A | |
Diluted EPS and Net Income | -0.003 N/A | |
Basic Weighted Average Shares | 10.2M N/A | |
Diluted Weighted Average Shares | 10.2M N/A | |
Balance Sheet | ||
Cash and Cash Equivalents | 748,721 N/A | |
Short-Term Investments | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 748,721 N/A | |
Total Current Assets | 8.7M N/A | |
Accumulated Depreciation | N/A N/A | |
Property and Plant and Equipment and Net | 111,245 N/A | |
Total Long-Term Assets | 690,171 N/A | |
Total Assets | 9.4M N/A | |
Income Taxes Payable | N/A N/A | |
Total Short-Term Debt | N/A N/A | |
Total Current Liabilities | 2.9M N/A | |
Total Long-Term Debt | N/A N/A | |
Total Long-Term Liabilities | 1.5M N/A | |
Total Liabilities | 4.4M N/A | |
Retained Earnings | 1.5M N/A | |
Total Stockholders Equity | 5.0M N/A | |
Total Shares Outstanding | 11.0M N/A | |
Cash Flow | ||
Cash from Operating Activities | 569,214 N/A | |
Capital Expenditures | N/A N/A | |
Cash from Investing Activities | -2.5M N/A | |
Dividends Paid | N/A N/A | |
Cash from Financing Activities | 2.0M N/A | |
Financials Ratio | ||
Gross Margin | N/A N/A | |
Operating Margin | N/A N/A | |
Return on Assets | N/A N/A | |
Return on Equity | N/A N/A | |
Revenue Growth | N/A N/A | |
Current Ratio | N/A N/A | |
Cash Ratio | N/A N/A | |
Debt-to-Equity Ratio | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow